NSAID-induced gastrointestinal adverse effects. In: Drug consults [intranet database]. Version 2.0. Greenwood Village (CO): Thomson Healthcare. Available: www.thomsonhc.com (accessed Sept. 19, 2011).
2.
RostomAMoayyediPHuntR; Canadian Association of Gastroenterology Consensus Group. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks. Aliment Pharmacol Ther2009;29:481-96.
SalpeterSRGregorPOrmistonTM. Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs. Am J Med2006;119:552-9.
6.
FarkouhMEGreenbergBP. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Cardiol2009;103:1227-37.
7.
BresalierRSSandlerRSQuanH. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med2005;352:1-11.
8.
TrelleSReichenbachSWandelS. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ2011;342:c7086.
9.
RayWAVaras-LorenzoCChungCP. Cardiovascular risks on nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes2009;2:155-63.
10.
BuenoHBardajiAPatrignaniP. Use of non-steroidal anti-inflammatory drugs and type-specific risk of acute coronary syndrome. Am J Cardiol2010;105:1102-6.
11.
KerrDJDunnJALangmanMJ. Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. N Engl J Med2007;357:360-9.
Aspirin. In: DRUGDEX System [intranet database]. Version 2.0. Greenwood Village (CO): Thomson Reuters (Healthcare). Available: www.thomsonhc.com (accessed Sept. 19, 2011).
14.
Agency for Healthcare Research and Quality. Heart attack risks, pain relief similar for most osteoarthritis drugs. Media Release: September26, 2006. Available: http://archive.ahrq.gov/news/press/pr2006/nsaidpr.htm (accessed July 15, 2011).
15.
SolomonSDWittesJFinnPV. Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials. Circulation2008;117:2104-13.
16.
LanasATorneroJZamoranoJL. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study. Ann Rheum Dis2010;69:1453-8.